Streetbeat News

Analyst Ratings

EMN

HUN

IFF

Three high-yielding stocks in the materials sector have been highlighted by Wall Street's most accurate analysts. These include Huntsman Corporation (HUN) with a dividend yield of 3.66%, Eastman Chemical Company (EMN) with a yield of 4.01%, and International Flavors & Fragrances Inc. (IFF) with a yield of 4.76%. Recent news for these companies include worse-than-expected Q2 results for HUN and IFF, and better-than-expected Q2 earnings for EMN.

Portfolio Pulse from Lisa Levin

September 18, 2023 | 5:28 pm

ANEB

H.C. Wainwright has initiated coverage on Anebulo Pharmaceuticals Inc (NASDAQ:ANEB) with a Buy rating and a price target of $6. The company is focused on developing therapy for acute cannabinoid intoxication (ACI) and has produced compelling clinical proof-of-concept data. The analysts note that positive pivotal data for ANEB-001 could make Anebulo an attractive acquisition target. ANEB-001 could be priced at $2.5K per administration and may ultimately achieve total sales approaching $500 million in the U.S. alone.

Portfolio Pulse from Vandana Singh

September 18, 2023 | 5:13 pm

CABA

Wells Fargo has maintained an Overweight rating on Cabaletta and raised its price target from $14 to $39. This has resulted in Cabaletta's shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:11 pm

BTCUSD

ETHUSD

SOLUSD

Crypto analyst Altcoin Sherpa has expressed concerns over Solana's (CRYPTO: SOL) current upward trajectory, warning of a potential sell-off and suggesting that the cryptocurrency might take some time to establish a solid bottom. The analyst advised those interested in SOL to slowly scale in and hold it for 2024+. However, Chris Burniske, a partner at the crypto-focused venture capital firm Placeholder, offered a different perspective, pointing out that only approximately 13% of FTX's SOL holdings are liquid.

Portfolio Pulse from Murtuza Merchant

September 18, 2023 | 5:05 pm

UNH

A significant bearish stance has been taken on UnitedHealth Group (NYSE:UNH) by a large investor, as observed in the unusual options activity. The sentiment among these big-money traders is split between 43% bullish and 56% bearish. The whales have been targeting a price range from $390.0 to $560.0 for UnitedHealth Group over the last 3 months. HSBC and Cantor Fitzgerald have downgraded their actions on UNH with price targets of $540 and $591 respectively.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 5:01 pm

VALE

Benzinga's options scanner detected over 12 options trades for Vale (NYSE:VALE) totaling $646,206. Whales have been targeting a price range from $10.0 to $16.0 for Vale over the last 3 months. JP Morgan maintains an Overweight rating on Vale with a price target of $18. The price of VALE is down -0.66% at $14.22.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 5:01 pm

OVV

Ovintiv (NYSE:OVV) has received 5 bullish and 7 indifferent analyst ratings in the last quarter. The average 12-month price target for Ovintiv has increased by 2.22% from the previous average price target of $48.67 to $49.75.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 5:01 pm

MTDR

In the last quarter, Matador Resources (NYSE:MTDR) received 7 analyst ratings, with 4 being bullish and 3 somewhat bullish. The company's average 12-month price target is $70.57, up 0.24% from the previous average of $70.40.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 5:01 pm

PBF

PBF Energy (NYSE:PBF) has received 7 analyst ratings in the last quarter, with 1 somewhat bullish and 6 indifferent. The company has an average 12-month price target of $56.43, which has increased by 12.48% over the past month. Analysts typically arrive at their conclusions by predicting a company's future earnings and the predictability of its revenue streams.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 5:00 pm

IMVT

Immunovant (NASDAQ:IMVT) has received 8 analyst ratings in the last quarter, all of which are bullish to some extent. The average price target is $31.0, indicating potential upside from the current price of $21.715. This average price target has increased by 12.73% over the past month.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 5:00 pm